Altered calcium-homeostasis of cisplatin-resistant non small cell (NSLC) and small cell lung (SCLC) cancer cells

被引：3
|
作者：
Bergner, A. [1 ]
Schroedl, K. [1 ]
Oelmez, H. [1 ]
Huber, R. M. [1 ]
机构：
[1] Univ Munich, Med Klin Innenstadt, D-8000 Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.22185
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
22185
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Effects of Nivolumab and Ipilimumab on the suppression of cisplatin resistant small cell lung cancer cells
    Chi, Wei
    Zhang, Lianyong
    Wang, Xue
    Li, Jingjing
    Li, Fei
    Ma, Yuxia
    Zhang, Qianyun
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (04) : 709 - 717
  • [42] ABCG2 regulates the pattern of self-renewing divisions in cisplatin-resistant non-small cell lung cancer cell lines
    Tang, Ying
    Hou, Jingming
    Li, Guanghui
    Song, Zongchang
    Li, Xiaojing
    Yang, Cui
    Liu, Wenying
    Hu, Yide
    Xu, Yu
    ONCOLOGY REPORTS, 2014, 32 (05) : 2168 - 2174
  • [43] Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced non- small cell lung cancer (NSCLC)
    Acharya, C.
    Hsu, D.
    Balakumaran, B.
    Walters, K.
    Vlahovic, V.
    Riedel, R.
    Garst, J.
    Febbo, P.
    Nevins, J.
    Potti, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [44] VALIDATION AND FUNCTION OF A NOVEL MIRNA SIGNATURE IN CISPLATIN RESISTANT NON-SMALL CELL LUNG CANCER CELLS
    Mac Donagh, Lauren A.
    Byrne, Kenneth O.
    Barr, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S443 - S444
  • [45] Differential Regulation of DNA Repair Genes in Cisplatin Resistant Non-Small Cell Lung Cancer Cells
    He, Yuexi
    Cuffe, Sinead
    Finn, Stephen
    O'Byrne, Kenneth J.
    Barr, Martin P.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S608 - S608
  • [46] CHEMOTHERAPY FOR CEREBRAL METASTASES IN SMALL CELL LUNG-CANCER (SCLC) AND NON-SMALL CELL LUNG-CANCER (NSCLC)
    TWELVES, C
    SOUHAMI, R
    HARPER, P
    TOBIAS, J
    SPIRO, S
    GEDDES, D
    ASH, C
    DRAKE, J
    THORAX, 1988, 43 (10) : P841 - P841
  • [47] KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung Cancer
    Jaromi, Luca
    Csongei, Veronika
    Vesel, Monika
    Abdelwahab, ElHusseiny Mohamed Mahmud
    Soltani, Amina
    Torok, Zsofia
    Smuk, Gabor
    Sarosi, Veronika
    Pongracz, Judit Erzsebet
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (10)
  • [48] Cisplatin and gemcitabine in non-small-cell lung cancer
    Cartei, G
    Sacco, C
    Sibau, A
    Pella, N
    Iop, A
    Tabaro, G
    ANNALS OF ONCOLOGY, 1999, 10 : 57 - 62
  • [49] Systemic Therapy of Extensive Stage Small Cell Lung Cancer (SCLC): Contrasting Therapeutic Principles for SCLC and Non-small Cell Lung Cancer (NSCLC) in 2015
    Murray, Nevin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S164 - S165
  • [50] Novel cytotoxics in small cell lung cancer (SCLC)
    Hirsh, Vera
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S245 - S246
12345